Training Features
Post-Market Surveillance, Vigilance & PMCF for Medical Devices Under the EU MDR
Gain practical skills to implement PMS, Vigilance, and PMCF under MDR and ensure continuous compliance and patient safety.
Format
Virtual Training
Level
Basic/Advanced
Date
27 July 2026
Time
14:00 - 18:00 CET
Duration
4 hours
Trainer
Jorn van Binsbergen
Certificate
Certificate included
Price
€ 595 or equivalent currency
Post-Market Surveillance, Vigilance, and PMCF Under EU MDR
Under the Medical Device Regulation (MDR) 2017/745, manufacturers must establish a proactive and systematic approach to Post-Market Surveillance (PMS), including Vigilance and Post-Market Clinical Follow-up (PMCF). These requirements ensure continuous monitoring of device safety and performance, providing updated clinical evidence throughout the product lifecycle.
Led by Jorn van Binsbergen, this interactive training helps medical device manufacturers understand and implement PMS, Vigilance, and PMCF in compliance with MDR. This course provides practical insights into regulatory requirements, data collection strategies, and best practices for ensuring compliance and readiness for Notified Body reviews. Participants will receive a certificate upon completion, confirming their understanding of PMS obligations under MDR.
Flexible Online Training Designed for MedTech Professionals
Participate from anywhere with our interactive virtual format, designed to fit your schedule while delivering in-depth, actionable content tailored to real-world regulatory challenges.
Upon successful completion of the program, participants receive a recognized certification, boosting their career prospects and demonstrating their expertise to employers and clients.
Certification and Career Advancement
Learn directly from regulatory experts with practical industry experience and gain clear, actionable insights into navigating x.
Expert-Led Training for Practical Compliance
Meet the Trainer
Jorn van Binsbergen
Jorn van Binsbergen is a clinical writer at Qserve Group, based in the Netherlands, contributing his expertise in clinical evaluations, regulatory affairs, and scientific writing to support the development and post-market assessment of medical devices.
